相关实验视频

Updated: Jul 1, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

循环RNAcirc_0096041通过海绵化miR-556-5p和调节LIN28A表达来促进骨髓瘤细胞的增殖和迁移

Fulin Zhou¹, Hao Wu², Zhen Yin³

¹Department of Orthopedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu 213003, China. zfulin@gmail.com.

Cellular and molecular biology (Noisy-le-Grand, France)

|March 2, 2024

概括

循环RNAcirc_0096041通过海绵化miR-556-5p和升调LIN28A (lin-28同源A) 来促进骨髓瘤的进展. 这一途径增强了瘤细胞的增殖和迁移,为骨髓瘤提供了新的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

LIN28A (lin-28同源A) 涉及骨髓瘤的发展,但有针对性的治疗方法有限.
循环RNAs (circRNAs) 越来越多地被认为是癌症进展中的角色.

研究的目的:

为了研究circ_0096041在骨髓瘤进展中的作用.
为了阐明涉及circ_0096041,miR-556-5p和LIN28A在骨髓瘤中的分子机制.

主要方法:

在骨髓瘤组织中分析circ_0096041的表达式.
生物信息预测和实验验证的circ_0096041海绵 miR-556-5p.
在体和体外验证LIN28A的向miR-556-5p.
在体外和体外功能测定以评估circ_0096041/miR-556-5p/LIN28A轴对骨髓瘤的影响.

主要成果:

Circ_0096041表达在骨髓瘤中显著上调,与预后不佳相关.
Circ_0096041 作为miR-556-5p的海绵作用.
在LIN28A直接针对miR-556-5p.
通过调节miR-556-5p/LIN28A轴,Circ_0096041促进骨髓瘤细胞的增殖和迁移.
在体内,Circ_0096041促进骨髓瘤转移.

结论:

Circ_0096041在促进骨髓瘤进展和转移方面发挥着至关重要的作用.
该circ_0096041/miR-556-5p/LIN28A轴代表了骨髓瘤中一种新的调节途径.
Circ_0096041是骨髓瘤治疗的潜在治疗点.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...